Jean-François Chatal. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antibodies, Monoclonal/therapeutic useEuropeHumansLymphoma, Follicular/radiotherapyLymphoma, Follicular/therapyRadioimmunotherapy/trendsStem Cell Transplantation/trendsTransplantation, AutologousYttrium Radioisotopes/therapeutic use
Substances: See more » Antibodies, MonoclonalYttrium Radioisotopesibritumomab tiuxetan
Year: 2006 PMID: 16480325 DOI: 10.1089/cbr.2006.21.1
Source DB: PubMed Journal: Cancer Biother Radiopharm ISSN: 1084-9785 Impact factor: 3.099